210 related articles for article (PubMed ID: 27108935)
61. Regulation of the 5-HT3A receptor-mediated current by alkyl 4-hydroxybenzoates isolated from the seeds of Nelumbo nucifera.
Youn UJ; Lee JH; Lee YJ; Nam JW; Bae H; Seo EK
Chem Biodivers; 2010 Sep; 7(9):2296-302. PubMed ID: 20860031
[TBL] [Abstract][Full Text] [Related]
62. Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression.
Dhar AK; Mahesh R; Jindal A; Devadoss T; Bhatt S
Chem Biol Drug Des; 2014 Dec; 84(6):721-31. PubMed ID: 24903617
[TBL] [Abstract][Full Text] [Related]
63. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
[TBL] [Abstract][Full Text] [Related]
64. Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.
Vernekar SK; Hallaq HY; Clarkson G; Thompson AJ; Silvestri L; Lummis SC; Lochner M
J Med Chem; 2010 Mar; 53(5):2324-8. PubMed ID: 20146481
[TBL] [Abstract][Full Text] [Related]
65. Investigation of 5-HT
Kojima SI; Kojima K; Fujita T
Eur J Pharmacol; 2017 Mar; 799():196-200. PubMed ID: 28189582
[TBL] [Abstract][Full Text] [Related]
66. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
67. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
Riga MS; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
[TBL] [Abstract][Full Text] [Related]
68. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats.
Ohno M; Watanabe S
Brain Res; 1997 Jul; 762(1-2):211-5. PubMed ID: 9262175
[TBL] [Abstract][Full Text] [Related]
69. Functional expression and properties of a nicotinic alpha9/5-HT3A chimeric receptor.
Verbitsky M; Plazas PV; Elgoyhen AB
Neuroreport; 2003 Oct; 14(15):1931-4. PubMed ID: 14561923
[TBL] [Abstract][Full Text] [Related]
70. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
[TBL] [Abstract][Full Text] [Related]
71. The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.
Baptista-Hon DT; Deeb TZ; Othman NA; Sharp D; Hales TG
Br J Pharmacol; 2012 Feb; 165(3):693-704. PubMed ID: 21740409
[TBL] [Abstract][Full Text] [Related]
72. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
73. Blockade of 5-HT3 receptors with granisetron does not affect trigeminothalamic nociceptive transmission in rats: Implication for migraine.
Sokolov AY; Sivachenko IB; Panteleev SS; Lyubashina OA
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):34-41. PubMed ID: 28853174
[TBL] [Abstract][Full Text] [Related]
74. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
Zwart R; Vijverberg HP
Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
[TBL] [Abstract][Full Text] [Related]
75. 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Navari RM
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2738-46. PubMed ID: 25838122
[TBL] [Abstract][Full Text] [Related]
76. Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons.
Walstab J; Krüger D; Stark T; Hofmann T; Demir IE; Ceyhan GO; Feistel B; Schemann M; Niesler B
Neurogastroenterol Motil; 2013 May; 25(5):439-47, e302. PubMed ID: 23490018
[TBL] [Abstract][Full Text] [Related]
77. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
[TBL] [Abstract][Full Text] [Related]
78. Visualising functional 5-HT
Abad IPL; Fam RL; Nguyen DT; Nowell CJ; Trinh PNH; Manallack DT; Freihat LA; Chakrabarti J; Jamil A; Exintaris B; Yaakob NS; Irving HR
Biomed Pharmacother; 2020 Dec; 132():110860. PubMed ID: 33059258
[TBL] [Abstract][Full Text] [Related]
79. Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.
Thompson AJ; Chau PL; Chan SL; Lummis SC
Biophys J; 2006 Mar; 90(6):1979-91. PubMed ID: 16387779
[TBL] [Abstract][Full Text] [Related]
80. Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT
Alix K; Khatri S; Mosier PD; Casterlow S; Yan D; Nyce HL; White MM; Schulte MK; Dukat M
ACS Chem Neurosci; 2016 Nov; 7(11):1565-1574. PubMed ID: 27533595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
